Arthur Bedrosian, Petitioner v. United States, et al.

  1. June 20, 2023

    Justices Won't Review Drug Exec's $1.4M Tax Penalty

    A former pharmaceutical executive lost his last chance to reduce a $1.4 million penalty for failing to report a foreign bank account when the U.S. Supreme Court declined on Tuesday to hear the case.

  2. May 16, 2023

    US Urges Justices Not To Review Drug Exec's $1M Tax Penalty

    The U.S. Supreme Court should not accept a drug company executive's challenge to lower courts' findings that there is an objective standard for his reckless failure to report foreign bank accounts, triggering a 50% penalty on the deposits that amounted to $1.4 million, the federal government said.

  3. January 03, 2023

    Ex-Pharma CEO Asks Justices To Review $1M In Tax Penalties

    A former pharmaceutical CEO asked the U.S. Supreme Court to review a Third Circuit decision upholding $1 million in Internal Revenue Service penalties against him for failing to report a Swiss bank account, saying the circuit wrongly considered his actions reckless.